BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34087994)

  • 1. Inhibition of EZH2 primes the cardiac gene activation via removal of epigenetic repression during human direct cardiac reprogramming.
    Tang Y; Zhao L; Yu X; Zhang J; Qian L; Jin J; Lu R; Zhou Y
    Stem Cell Res; 2021 May; 53():102365. PubMed ID: 34087994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers.
    Au SL; Wong CC; Lee JM; Wong CM; Ng IO
    PLoS One; 2013; 8(6):e68226. PubMed ID: 23826380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow-dependent epigenetic regulation of IGFBP5 expression by H3K27me3 contributes to endothelial anti-inflammatory effects.
    Xu S; Xu Y; Yin M; Zhang S; Liu P; Koroleva M; Si S; Little PJ; Pelisek J; Jin ZG
    Theranostics; 2018; 8(11):3007-3021. PubMed ID: 29896299
    [No Abstract]   [Full Text] [Related]  

  • 4. Demethylation of H3K27 Is Essential for the Induction of Direct Cardiac Reprogramming by miR Combo.
    Dal-Pra S; Hodgkinson CP; Mirotsou M; Kirste I; Dzau VJ
    Circ Res; 2017 Apr; 120(9):1403-1413. PubMed ID: 28209718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A.
    Wang K; Jiang X; Jiang Y; Liu J; Du Y; Zhang Z; Li Y; Zhao X; Li J; Zhang R
    J Exp Clin Cancer Res; 2023 Nov; 42(1):320. PubMed ID: 38008711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between EZH2 and G9a Regulates CXCL10 Gene Repression in Idiopathic Pulmonary Fibrosis.
    Coward WR; Brand OJ; Pasini A; Jenkins G; Knox AJ; Pang L
    Am J Respir Cell Mol Biol; 2018 Apr; 58(4):449-460. PubMed ID: 29053336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-patterning of H3K27me3, H3K4me3 and DNA methylation during fibroblast conversion into induced cardiomyocytes.
    Liu Z; Chen O; Zheng M; Wang L; Zhou Y; Yin C; Liu J; Qian L
    Stem Cell Res; 2016 Mar; 16(2):507-18. PubMed ID: 26957038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated EZH2 in ischemic heart disease epigenetically mediates suppression of Na
    Zhao L; You T; Lu Y; Lin S; Li F; Xu H
    J Mol Cell Cardiol; 2021 Apr; 153():95-103. PubMed ID: 33370552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H3K27me3 is an epigenetic barrier while KDM6A overexpression improves nuclear reprogramming efficiency.
    Zhou C; Wang Y; Zhang J; Su J; An Q; Liu X; Zhang M; Wang Y; Liu J; Zhang Y
    FASEB J; 2019 Mar; 33(3):4638-4652. PubMed ID: 30673507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA JPX targets SERCA2a to mitigate myocardial ischemia/reperfusion injury by binding to EZH2.
    Bao J; Zhang C; Chen J; Xuan H; Wang C; Wang S; Yin J; Liu Y; Li D; Xu T
    Exp Cell Res; 2023 Jun; 427(1):113572. PubMed ID: 36990422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JMJD3 aids in reprogramming of bone marrow progenitor cells to hepatic phenotype through epigenetic activation of hepatic transcription factors.
    Kochat V; Equbal Z; Baligar P; Kumar V; Srivastava M; Mukhopadhyay A
    PLoS One; 2017; 12(3):e0173977. PubMed ID: 28328977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ezh2 mediated H3K27me3 activity facilitates somatic transition during human pluripotent reprogramming.
    Rao RA; Dhele N; Cheemadan S; Ketkar A; Jayandharan GR; Palakodeti D; Rampalli S
    Sci Rep; 2015 Feb; 5():8229. PubMed ID: 25648270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezh2 is not required for cardiac regeneration in neonatal mice.
    Ahmed A; Wang T; Delgado-Olguin P
    PLoS One; 2018; 13(2):e0192238. PubMed ID: 29466371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MALAT1 Regulates USP22 Expression Through EZH2-Mediated H3K27me3 Modification to Accentuate Sepsis-Induced Myocardial Dysfunction.
    Xu H; Ye W; Shi B
    Cardiovasc Toxicol; 2022 Sep; 22(9):813-830. PubMed ID: 35726125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Inflammation Pathway NF-κB Cooperates with Epigenetic Reprogramming to Drive the Malignant Progression of Glioblastoma.
    Lin K; Gao W; Chen N; Yang S; Wang H; Wang R; Xie F; Meng J; Lam EW; Li S; Cheng W; Chen P; Wu H; Yan J; Jin D; Jin B
    Int J Biol Sci; 2022; 18(15):5770-5786. PubMed ID: 36263173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA H19-EZH2 interaction promotes liver fibrosis via reprogramming H3K27me3 profiles.
    Li XJ; Zhou F; Li YJ; Xue XY; Qu JR; Fan GF; Liu J; Sun R; Wu JZ; Zheng Q; Liu RP
    Acta Pharmacol Sin; 2023 Dec; 44(12):2479-2491. PubMed ID: 37580495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion.
    Yi X; Guo J; Guo J; Sun S; Yang P; Wang J; Li Y; Xie L; Cai J; Wang Z
    Sci Rep; 2017 Jun; 7(1):3568. PubMed ID: 28620234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin gene-related peptide regulates spinal microglial activation through the histone H3 lysine 27 trimethylation via enhancer of zeste homolog-2 in rats with neuropathic pain.
    An Q; Sun C; Li R; Chen S; Gu X; An S; Wang Z
    J Neuroinflammation; 2021 May; 18(1):117. PubMed ID: 34020664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EZH2-induced H3K27me3 is associated with epigenetic repression of the ARHI tumor-suppressor gene in ovarian cancer.
    Fu Y; Chen J; Pang B; Li C; Zhao J; Shen K
    Cell Biochem Biophys; 2015 Jan; 71(1):105-12. PubMed ID: 25077680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma.
    Tsou PS; Campbell P; Amin MA; Coit P; Miller S; Fox DA; Khanna D; Sawalha AH
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3695-3702. PubMed ID: 30755532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.